glp-1 oral drugs New Guidelines for Type 2 Diabetes in 2025 The challenge of developing oral
Description
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a newer class of antidiabetic medications originally approved for type 2 diabetes management
He Z, Tabe AN, Rana S, King K
doi: 10.4103/1673-5374.306060 [DOI] [PMC free article] [PubMed] [Google Scholar] 76
8.3% of participants reported using them for four months
Oral medications may feel easier to obtain, easier to hide, and easier to misuse
( Epub 20220622 )
